Inventor
GENG LIFENG
US20 patents
⚠️ This page may combine multiple inventors who share the name “GENG LIFENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEARLE & CO
8 patentsUS6087496AJul 11, 2000
Substituted pyrazoles suitable as p38 kinase inhibitors
SEARLE & CO101 citations99
US5932576AAug 3, 1999
3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
SEARLE & CO155 citations98
US6423713B1Jul 23, 2002
Substituted pyrazoles as p38 kinase inhibitors
SEARLE & CO90 citations97
US6617324B1Sep 9, 2003
Substituted pyrazoles as p38 kinase inhibitors
SEARLE & CO47 citations96
US6525059B1Feb 25, 2003
Substituted pyrazoles as p38 kinase inhibitors
SEARLE & CO62 citations96
US6514977B1Feb 4, 2003
Substituted pyrazoles as p38 kinase inhibitors
SEARLE & CO70 citations96
US6335336B1Jan 1, 2002
3(5)-Heteroaryl substituted pyrazoles as p38 kinase inhibitors
SEARLE & CO31 citations92
US7019005B2Mar 28, 2006
3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
SEARLE & CO3 citations63
PHARMACIA CORP
7 patentsUS6979686B1Dec 27, 2005
Substituted pyrazoles as p38 kinase inhibitors
PHARMACIA CORP64 citations96
US6579873B2Jun 17, 2003
3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
PHARMACIA CORP14 citations92
US6849653B2Feb 1, 2005
Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
PHARMACIA CORP18 citations84
US7153959B2Dec 26, 2006
Substituted pyrazoles as p38 kinase inhibitors
PHARMACIA CORP6 citations73
US7071198B1Jul 4, 2006
Substituted pyrazoles as p38 kinase inhibitors
PHARMACIA CORP7 citations73
US7186743B2Mar 6, 2007
Substituted pyrazolyl compounds for the treatment of inflammation
PHARMACIA CORP7 citations71
US6956052B2Oct 18, 2005
Substituted pyrazolyl compounds for the treatment of inflammation
PHARMACIA CORP6 citations71